Automated quality inspection has a reputation problem. If you ask production managers why they haven't implemented it yet, the might include: too complex, too expensive, requires expertise we don't have.
When it comes to pharmaceutical manufacturing, precision is more than a performance goal, it is a regulatory necessity. Miriam Krechlok, segment marketing manager, Mettler-Toledo Product Inspection discusses.
Tobias Lurk, global product performance manager at TÜV SÜD Management Service, explores how pharmaceutical manufacturers can navigate the revised ISO 14001 standard by strengthening existing management systems rather than starting from scratch.
ACG Packaging Materials has strengthened its commitment to customers across Europe following the successful certification of its Croatia warehouse and slitting facility to both the ISO 9001:2015 and EN ISO 15378:2017 standards.
Gaelic Laboratories, a GMP-approved manufacturer of Beta-Lactam antibiotics, has successfully obtained BSI Kitemark Certification for Minimised Risk of Antimicrobial Resistance (AMR), demonstrating a commitment to responsible manufacturing.
Paul Barr, senior chemistry consultant at testing and regulatory specialist Broughton, outlines why a unified approach is essential and increasingly expected.
Jordan Smith marketing & sales operations coordinator, ScreenerKing explains why particle screening is a hidden quality-control step in pharmaceutical powder processing.
Chris Allen, CEO of contract research organisation Broughton, explains the critical role of laboratory information management systems (LIMS) in supporting these requirements.
Beccy Bell, operations director at testing and regulatory specialist Broughton, examines how stability study management shifts as data moves beyond contained documentation and begins to inform decisions for products already on the market.
Matt Cokely, global technical consultant director at Ecolab explores how rapid recovery in a GMP environment means restoring control through predefined, risk-based and inspection-defensible strategies that protect sterility assurance under pressure.
Emmet Tilley, quality director at scientific and regulatory consultancy Broughton Group, outlines how creating a quality culture through established practices with new perspectives enables growth while maintaining regulatory integrity.
